|
|
Volumn 2, Issue 1, 1999, Pages 13-26
|
|
Does the evidence from clinical trials justify the treatment of hypertension?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ADULT;
AGE;
AGED;
CLINICAL TRIAL;
DIABETES MELLITUS;
FEMALE;
HUMAN;
HYPERTENSION;
MALE;
MIDDLE AGED;
MORTALITY;
PREVALENCE;
REVIEW;
RISK FACTOR;
SURVIVAL;
ADRENERGIC BETA-ANTAGONISTS;
ADULT;
AGE FACTORS;
AGED;
AGED, 80 AND OVER;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTIHYPERTENSIVE AGENTS;
CLINICAL TRIALS;
DIABETES COMPLICATIONS;
DIABETES MELLITUS;
FEMALE;
HUMANS;
HYPERTENSION;
MALE;
MIDDLE AGED;
PREVALENCE;
RISK FACTORS;
SURVIVAL ANALYSIS;
|
|
EID: 0033253801
PISSN: 10983597
EISSN: None
Source Type: Journal
DOI: 10.1016/S1098-3597(99)90079-0 Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
